Prediagnosis aspirin use and outcomes in a prospective cohort of esophageal cancer patients.
about
NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysisAspirin enhances the cytotoxic activity of bortezomib against myeloma cells via suppression of Bcl-2, survivin and phosphorylation of AKT.Variation by stage in the effects of prediagnosis weight loss on mortality in a prospective cohort of esophageal cancer patients.
P2860
Prediagnosis aspirin use and outcomes in a prospective cohort of esophageal cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prediagnosis aspirin use and o ...... of esophageal cancer patients.
@en
Prediagnosis aspirin use and o ...... of esophageal cancer patients.
@nl
type
label
Prediagnosis aspirin use and o ...... of esophageal cancer patients.
@en
Prediagnosis aspirin use and o ...... of esophageal cancer patients.
@nl
prefLabel
Prediagnosis aspirin use and o ...... of esophageal cancer patients.
@en
Prediagnosis aspirin use and o ...... of esophageal cancer patients.
@nl
P2093
P2860
P356
P1476
Prediagnosis aspirin use and o ...... of esophageal cancer patients.
@en
P2093
Adriana Rodriguez
Alfred I Neugut
Cathy F Spinelli
James L Araujo
Joshua R Sonett
Julian A Abrams
Kivilcim Sungur-Stasik
Nasser K Altorki
P2860
P304
P356
10.1177/1756283X16657985
P577
2016-07-15T00:00:00Z